Huberman E, Callaham M F
Proc Natl Acad Sci U S A. 1979 Mar;76(3):1293-7. doi: 10.1073/pnas.76.3.1293.
Human promyelocytic leukemia cells (HL-60) were induced to differentiate into mature cells by the tumor-promoting agent phorbol-12-myristate-13-acetate and other related phorbol diesters. Differentiation was determined by an increase in the percent of myelocytes, metamyelocytes, and other mature myeloid cells as well as by an increase in the percent of phagocytizing cells. Induction of differentiation could be determined after 2 days of treatment with phorbol-12-myristate-13-acetate at a dose as low as 6 X 10(11) M. A correlation was found between reported tumor-promoting activity of a series of phorbol esters and their ability to induce myeloid differentiation and to inhibit cell growth. It is suggested that tumor-promoting agents like chemicals that induce terminal differentiation in these cells, at extremely low concentrations, may be used as a tool in the study of the control of cell growth, cell differentiation, and malignancy in human leukemic cells.
人早幼粒细胞白血病细胞(HL - 60)可被促肿瘤剂佛波醇 - 12 - 肉豆蔻酸酯 - 13 - 乙酸酯及其他相关佛波醇二酯诱导分化为成熟细胞。通过髓细胞、晚幼粒细胞及其他成熟髓系细胞百分比的增加以及吞噬细胞百分比的增加来确定分化情况。在用低至6×10⁻¹¹ M的佛波醇 - 12 - 肉豆蔻酸酯 - 13 - 乙酸酯处理2天后即可确定分化诱导情况。发现一系列佛波醇酯的报告促肿瘤活性与其诱导髓系分化及抑制细胞生长的能力之间存在相关性。有人提出,像能在极低浓度下诱导这些细胞终末分化的化学物质这类促肿瘤剂,可用作研究人类白血病细胞中细胞生长控制、细胞分化和恶性肿瘤的工具。